Questcor Pharmaceuticals, Inc. (Headquarters) (JOBS) Sees Lower Q3 Acthar Sales
Reuters -- Questcor Pharmaceuticals Inc said it expects third-quarter sales of its gel Acthar for treatment of infantile spasms (IS) to be about 20 percent lower than the 161 new, shipped and paid prescriptions in the second quarter.